MyWealthGrowth.com logo
HomeMutual Funds

Nippon India Pharma Fund

Nippon India Pharma Fund

Regular PlanGrowth Option

Fund Performance

Lumpsum

SIP

26.20

as on 30 Sep 2022

3 Years

Investment of ₹ 10,000 in this fund 3 Years back would be ₹ 20,112 today.

Invest Now

NAV Performance

Nippon India Pharma Fund performance graph for last 3 years
Performance of Nippon India Pharma Fund for last 3 Years

Fund Information

  • ₹ 282.169

    as on 30 Sep 2022
  • Regular - Growth

  • -

  • ₹ 5,000

  • ₹ 5,224 Cr.

    as on 31 Dec 2021
  • 2%

  • 02 Jan 2013

  • Equity - Sectoral/Thematic

  • S&P BSE Healthcare TRI

  • Nippon India Mutual Fund

    Show All Funds
  • Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges.

Highlights of this fund

Nippon India Pharma Fund is an Open-ended Equity Fund. The fund belongs to Sectoral/Thematic category, where the investment is done in predominantly in stocks that are listed on Stock Exchanges like the Bombay Stock Exchange (BSE) or the National Stock Exchange (NSE) in India as well as Global stock exchanges like the Dow Jones, London Stock Exchange or LSE etc. This fund was started on 02 Jan 2013. This fund is offered by one of the top AMC (Assets Management Company) Nippon India Mutual Fund. You can also view here all other Equity funds offered by Nippon India Mutual Fund.

Latest NAV of the fund is ₹ 282.169 as on 30 Sep 2022.

This fund has 9 years of track record. Since 30 Nov 2021 expense ratio of this fund is 2%. Ideally you shoulds compare this fund with the benchmark S&P BSE Healthcare TRI.

You can invest in this fund in SIP with the minimum investment of ₹ 100. Lumpsum invest is offered with minimum investment of ₹ 5,000.

Fund Objective

To generate consistent returns by investing in equity,equity related of fixed income securities of Pharma and other associated companies.

List of Fund Managers of Nippon India Pharma Fund

  • About Sailesh Raj Bhan

    Picture of Sailesh Raj BhanMr. Sailesh Raj Bhan has over 24 years of experience in Indian Equity Markets with over 15 years at Reliance Nippon Life Asset Management Limited in Fund Management. He manages the flagship diversified equity schemes like Reliance Multi Cap Fund (previously Reliance Equity Opportunities Fund) - a strategy with assets of over Rs10,000cr ($1.5bn) since its inception in March 2005 and Reliance Large Cap Fund (previously Reliance Top200 Fund) – with assets of over Rs13000cr (over $1.8bn) since its inception 2007. Sailesh also manages the Largest Pharma Sector Fund in India since its inception 15 years back in May 2004, in addition to managing Reliance Consumption Fund – a broad based Consumption Thematic product since 2004. He also advises on international mandates for some strategies for the last 5 years.

Riskometer : Risk associated with this fund

Investors understand that their principal will be at High Risk

Fund Return Comparison

Fund Name 1 Month 3 Months 6 Months 1 Year 2 Years 3 Years 5 Years 10 Years 1 Year 2 Years 3 Years 5 Years 10 Years
Category Best 3.22% 20.14% 19.11% 22.13% 58.62% 38.35% 25.71% 20.60% 28.93% 37.93% 47.30% 31.95% 21.31%
Category Average -1.77% 11.46% 2.11% 0.54% 28.03% 18.37% 11.43% 13.38% 5.07% 14.35% 20.36% 15.42% 13.52%
Nippon India Pharma Fund 2.14%₹ 10,213 7.93%₹ 10,792 -3.01%₹ 9,698 -8.27%₹ 9,173 -2.90%₹ 11,811 11.87%₹ 12,513 3.12%₹ 24,784 26.20%₹ 20,112 15.59%₹ 45,369 16.96%₹ 21,908 17.21%₹ 92,244 15.75%₹ 43,259 14.50%₹ 2,56,158
Quant Infrastructure Fund -0.82%₹ 9,917 17.02%₹ 11,701 7.21%₹ 10,720 15.82%₹ 11,582 17.20%₹ 13,091 58.62%₹ 25,161 37.93%₹ 34,132 38.35%₹ 26,504 47.30%₹ 69,159 21.54%₹ 26,553 31.95%₹ 1,31,412 15.62%₹ 42,762 21.17%₹ 3,67,097
Quant Consumption Fund 1.54%₹ 10,154 16.08%₹ 11,607 4.22%₹ 10,421 5.62%₹ 10,562 13.54%₹ 12,863 41.48%₹ 20,017 27.18%₹ 31,128 36.43%₹ 25,415 38.21%₹ 61,651 18.28%₹ 23,173 27.37%₹ 1,17,903 17.79%₹ 51,523 21.31%₹ 3,69,971
Mirae Asset Healthcare Fund 1.62%₹ 10,161 9.32%₹ 10,931 -2.94%₹ 9,706 -7.63%₹ 9,236 -2.05%₹ 11,866 12.27%₹ 12,604 5.17%₹ 25,304 29.45%₹ 21,708 18.25%₹ 47,115 - - - -
ICICI Prudential Technology Fund -3.60%₹ 9,639 -1.56%₹ 9,844 -21.64%₹ 7,836 -18.79%₹ 8,121 -25.07%₹ 10,299 25.61%₹ 15,777 3.18%₹ 24,800 28.96%₹ 21,464 24.91%₹ 51,676 25.71%₹ 31,427 23.77%₹ 1,08,154 20.60%₹ 65,214 20.11%₹ 3,46,598
DSP Healthcare Fund 3.22%₹ 10,321 8.61%₹ 10,861 -4.63%₹ 9,537 -9.78%₹ 9,021 -4.72%₹ 11,691 9.38%₹ 11,963 1.94%₹ 24,488 28.53%₹ 21,245 15.91%₹ 45,576 - - - -

Portfolio Holdings

Portfolio holdings pattern of Nippon India Pharma Fund as on 02 Oct 2022 are listed below:

  • Equity Holdings:

    99.12%
  • Debt Holdings:

    0.00%
  • Others Holdings:

    0.88%

Top Sector Holdings of Nippon India Pharma Fund

Name of SectorHolding PercentageHolding Values in Crore
Pharmaceuticals 76.57% ₹ 4,131.98 Cr.
Hospital 16.57% ₹ 894.34 Cr.
Healthcare service providers 5.47% ₹ 295.34 Cr.
Medical equipment & supplies 0.51% ₹ 27.79 Cr.
Others .88% -

Top Stock Holdings of Nippon India Pharma Fund

Name of StocksHolding PercentageHolding Values in Crore
Sun Pharmaceutical Industries Ltd. 11.91% ₹ 642.82 Cr.
Dr. Reddys Laboratories Ltd. 9.55% ₹ 515.24 Cr.
Cipla Ltd. 8.75% ₹ 472.05 Cr.
Aurobindo Pharma Ltd. 7.62% ₹ 411.24 Cr.
Lupin Ltd. 7.40% ₹ 399.32 Cr.
Others 54.77% -

Other Holdings

Holding TypeHolding Percentage
TREPS 1.17%
Margin 0.17%
Net Receivables -0.46%